Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
StromaForte in Aging Frailty
NCT06063590Phase 2Completed
- Sponsor
- Cellcolabs
- Start
- Jan 2024
- Primary completion
- Aug 2025
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of StromaForte in frailty syndrome, sponsored by Cellcolabs. Started Jan 2024; status: completed.
02
Drugs
StromaForte
03
Conditions
frailty syndrome
Beyond the preview
Go deeper on NCT06063590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06063590.